Mycobacterium chelonae infection with multiple cutaneous lesions after treatment with acupuncture

International Journal of Dermatology

Volumn 42, Issue 8, 2003, Pages 642-644

  Ara, Mariano ^a,b   Sáenz De Santamaría, Carmen ^a,b   Zaballos, Pedro ^a,b   Yus, Carmen ^a,b   Lezcano, María Antonia ^a,b  

^a Hospital Migueal Servet   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; IMIPENEM; OFLOXACIN; TOBRAMYCIN;

ABSCESS; ACID FAST BACTERIUM; ACUPUNCTURE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM IDENTIFICATION; CASE REPORT; CONFERENCE PAPER; CONTAMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; INFLAMMATORY CELL; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; NECROSIS; NONHUMAN; OBESITY; PANNICULITIS; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SKIN BIOPSY; SKIN DEFECT; SUBCUTANEOUS NODULE; TISSUE CULTURE;

ACUPUNCTURE THERAPY; FEMALE; HUMANS; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; PANNICULITIS;

EID: 0042889240     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01639_3.x     Document Type: Conference Paper

References (25)

1. Metchock BG, Nolte FS, Wallace RJ. Mycobacterium. In: Murray, PR, Baron, EJ, Pfaller, MA, Tenover, FC, Yolken, RH, eds. Manual of Clinical Microbiology, 7th edn. Washington: DC. American Society for Microbiology, 1999: 399-437.
2. Kusunoki S, Ezaki T. Proposal of Mycobacterium peregrinum sp. nov., nom. rev. & elevation of Mycobacterium chelonae subsp. abscessus (Kubica, et al.) to species status: Mycobacterium abscessus comb. nov. Int J Sys Bacteriol 1992; 42: 240-245
3. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9: 177-215.
4. Wallace RJ, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: Importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166: 405-412.
5. Swetter SM, Kindel SE, Smoller BR. Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. J Am Acad Dermatol 1993; 28: 352-355.
6. Murdoch ME, Leigh IM. Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol 1989; 14: 309-312.
7. Joop-McKay AG, Randell P. Sporotrichoid cutaneous infection due to Mycobacterium chelonei in a renal transplant patient. Australas J Dermatol 1990; 31: 105-109.
8. Jackson PG, Keen H, Noble CJ, Simmons NA. Injection abscesses due to Mycobacterium chelonei occurring in a diabetic patient. Tubercle 1981; 62: 277-279.
9. Escobedo JA, Gil D, Pascual A, Aguirre JM. Infección cutánea por Mycobacterium chelonae tras autoinyección de insulina con pluma. Enferm Infecc Microbiol Clin 1994; 12: 274-275.
10. Inman PM, Beck A, Brown AE, Stanford JL. Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol 1969; 100: 141-147.
11. Borghans JGA, Stanford JL. Mycobacterium chelonei in abscesses after injection of diphteria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 1973; 107: 1-8.
12. Petrini B, Hellstrand P, Eriksson M. Infection with Mycobacterium chelonei following injections. Scand J Infect Dis 1980; 12: 237-238.
13. Gremillion DH, Mursch SB, Lerner CJ. Injection site abscesses caused by Mycobacterium chelonei. Infect Control 1983: 4: 25-28.
14. Wenger JD, Spika JS, Smithwick RW, et al. Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. JAMA 1990; 264: 373-376.
15. Camargo D, Saad C, Ruiz F, et al. Iatrogenic outbreak of M. chelonae skin abscesses. Epidemiol Infect; 117: 113-119, 1996.
16. Villanueva A, Villanueva Calderón R, Acosta Vargas B, et al. Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis 1997; 24: 1147-1153.
17. Valencia IC, Weiss E, Sukenik E, Kerdel FA. Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells. Int J Dermatol; 38: 770-773, 1999.
18. Galil K, Miller LA, Yakrus MA, et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis; 5: 681-687, 1999.
19. Fariña Sabaris MC, Soriano Pérez ML, Esteban J, et al. Foliculitis por Mycobacterium chelonae en dos pacientes inmunocompetentes. Actas Dermosifiliogr; 86: 676-680, 1995.
20. Herrero JB, Borbujo C, Román MT, et al. Infección cutánea por Mycobacterium chelonae. Presentación de tres casos con lesiones múltiples. Rev Clin Esp; 196: 606-609, 1996.
21. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med; 119: 482-486, 1993.
22. Tebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis; 20: 443-444, 1995.
23. Driscoll MS, Tyring SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol; 36: 495-496, 1997.
24. Bañuls J, Ramón R, Pascual E, et al. Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis. Br J Dermatol; 143: 1345, 2000.
25. Nathan DL, Singh S, Kestenbaum TM, Casparian JM. Cutaneous Mycobacterium chelonae in a liver transplant patient. J Am Acad Dermatol 2000; 43: 333-336.